Clarium vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $27M Series A led by Northzone with Kaiser Permanente Ventures and General Catalyst. First AI supply chain resiliency platform built specifically for hospital systems.
About
Clarium is the first AI-powered supply chain resiliency platform built specifically for hospital health systems, providing real-time intelligence about supply chain disruptions before they cause care delivery failures. The company raised $27 million in Series A financing led by Northzone, with Kaiser Permanente Ventures, General Catalyst, and Cleveland Clinic participating. A former Kaiser Permanente Chief Supply Chain Officer joined as strategic advisor in Q1 2026.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.